Scientists are currently performing clinical studies which focus on immunology (the immune system,) and are attempting to determine if there is a genetic correlation to multiple sclerosis and calcium levels. They are also analyzing the environment as more people are affected in areas further from the equator. This may also be related to a lack of vitamin D. Infections and viruses can also have an impact on MS. Determining the primary factors of the disease can only help provide a solution in the near future. The four classifications of MS are as follows:

1. Relapsing-remitting MS – Flare-ups are followed by remissions, which may last for days or months. Symptoms may be mild to severe. Greater than 80 percent of people initially have this type of MS.
2. Secondary progressive MS – This phase occurs to those that are experiencing the relapse-remitting phase, but the disability no longer fades between cycles. The disease progressively worsens until the patient has a steady progression of disability.
3. Primary-progressive MS – This stage progresses slowly, but steadily from the onset. Symptoms usually do not decrease in intensity, and there are no remissions. Approximately 15 percent have PPMS.
4. Progressive-relapsing MS – This rare form of MS involves symptoms that continually worsen and also attacks during remission periods.

Calcium deficiency is not considered a direct cause of MS; however, when combined with vitamin D and magnesium it will lessen nerve tissue damage and bone loss. Before beginning any new supplement, consult with your primary physician as the risk of an interaction with other medications is possible.

A clinical study conducted by P. Goldberg found that MS patients between the ages of 22 and 37 had less MS exacerbations when they took calcium, magnesium and vitamin D over a two year period of time. He concluded that these nutrients strengthened the myelin sheath to withstand damage caused by multiple sclerosis.

Another study of 300 people used Calcium 2-amino ethyl phosphoric acid (Ca-AEP) over two decades. The Ca-AEP proved beneficial in 82 percent of the people, and 92 percent of patients that were in the early stages of the disease.

There are several medications used to reduce the disease activity and progression, but no actual cures are available at this time. For more information regarding calcium levels and MS, refer to Chapter 6 of the MS – Living Symptom Free book.